327 related articles for article (PubMed ID: 19601824)
1. Metabolite identification and profiling in drug design: current practice and future directions.
Zhang Z; Zhu M; Tang W
Curr Pharm Des; 2009; 15(19):2220-35. PubMed ID: 19601824
[TBL] [Abstract][Full Text] [Related]
2. Drug metabolism and pharmacokinetics in support of drug design.
Tang W; Lu AY
Curr Pharm Des; 2009; 15(19):2170-83. PubMed ID: 19601821
[TBL] [Abstract][Full Text] [Related]
3. High-throughput in vitro profiling assays: lessons learnt from experiences at Novartis.
Faller B; Wang J; Zimmerlin A; Bell L; Hamon J; Whitebread S; Azzaoui K; Bojanic D; Urban L
Expert Opin Drug Metab Toxicol; 2006 Dec; 2(6):823-33. PubMed ID: 17125403
[TBL] [Abstract][Full Text] [Related]
4. The role of hyphenated chromatography-mass spectrometry techniques in exploratory drug metabolism and pharmacokinetics.
Hsieh Y; Korfmacher W
Curr Pharm Des; 2009; 15(19):2251-61. PubMed ID: 19601826
[TBL] [Abstract][Full Text] [Related]
5. Perspectives of pharmacokinetics and metabolism in drug design.
Hsieh Y
Curr Pharm Des; 2009; 15(19):2169. PubMed ID: 19601820
[No Abstract] [Full Text] [Related]
6. Organic chemistry in drug discovery.
MacCoss M; Baillie TA
Science; 2004 Mar; 303(5665):1810-3. PubMed ID: 15031494
[TBL] [Abstract][Full Text] [Related]
7. Biosensor profiling of molecular interactions in pharmacology.
Cooper MA
Curr Opin Pharmacol; 2003 Oct; 3(5):557-62. PubMed ID: 14559103
[TBL] [Abstract][Full Text] [Related]
8. Drug-like property concepts in pharmaceutical design.
Di L; Kerns EH; Carter GT
Curr Pharm Des; 2009; 15(19):2184-94. PubMed ID: 19601822
[TBL] [Abstract][Full Text] [Related]
9. Metabolism and toxicity of drugs. Two decades of progress in industrial drug metabolism.
Baillie TA
Chem Res Toxicol; 2008 Jan; 21(1):129-37. PubMed ID: 18052111
[TBL] [Abstract][Full Text] [Related]
10. Role of metabolism and pharmacokinetic studies in the discovery of new drugs--present and future perspectives.
Humphrey MJ; Smith DA
Xenobiotica; 1992 Jul; 22(7):743-55. PubMed ID: 1455898
[TBL] [Abstract][Full Text] [Related]
11. Successful drug discovery.
Swinney DC
Curr Top Med Chem; 2006; 6(5):403-4. PubMed ID: 16719799
[No Abstract] [Full Text] [Related]
12. Control systems engineering in continuous pharmaceutical manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
Myerson AS; Krumme M; Nasr M; Thomas H; Braatz RD
J Pharm Sci; 2015 Mar; 104(3):832-9. PubMed ID: 25546650
[TBL] [Abstract][Full Text] [Related]
13. High-throughput screening approaches for investigating drug metabolism and pharmacokinetics.
Roberts SA
Xenobiotica; 2001; 31(8-9):557-89. PubMed ID: 11569526
[TBL] [Abstract][Full Text] [Related]
14. Applications of high-throughput ADME in drug discovery.
Kassel DB
Curr Opin Chem Biol; 2004 Jun; 8(3):339-45. PubMed ID: 15183334
[TBL] [Abstract][Full Text] [Related]
15. The evolving role of drug metabolism in drug discovery and development.
Yengi LG; Leung L; Kao J
Pharm Res; 2007 May; 24(5):842-58. PubMed ID: 17333392
[TBL] [Abstract][Full Text] [Related]
16. The pivotal role of drug metabolism and pharmacokinetics in the discovery and development of new medicines.
Alavijeh MS; Palmer AM
IDrugs; 2004 Aug; 7(8):755-63. PubMed ID: 15334309
[TBL] [Abstract][Full Text] [Related]
17. Requirements for a lead compound to become a clinical candidate.
Hefti FF
BMC Neurosci; 2008 Dec; 9 Suppl 3(Suppl 3):S7. PubMed ID: 19091004
[TBL] [Abstract][Full Text] [Related]
18. Hit and Lead identification: efficient practices for drug discovery.
Goodnow RA; Gillespie P
Prog Med Chem; 2007; 45():1-61. PubMed ID: 17280901
[No Abstract] [Full Text] [Related]
19. The role of exploratory drug metabolism and pharmacokinetics in new drug research: case study-selection of a thrombin receptor antagonist for development.
Hsieh Y; Cheng KC; Wang Y; Chackalamannil S; Xia Y; Korfmacher WA; White RE
Curr Pharm Des; 2009; 15(19):2262-9. PubMed ID: 19601827
[TBL] [Abstract][Full Text] [Related]
20. Challenges and solutions to metabolites in safety testing: impact of the International Conference on Harmonization M3(R2) guidance.
Yu H; Bischoff D; Tweedie D
Expert Opin Drug Metab Toxicol; 2010 Dec; 6(12):1539-49. PubMed ID: 21067462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
